AZOLOPYRIMIDIN ZUR BEHANDLUNG VON KREBSBEDINGTEN ERKRANKUNGEN

• 收藏
• 分享

专利权人:

Arcus Biosciences; Inc.

发明人:

BEATTY, Joel,DEBIEN, Laurent,JEFFREY, Jenna,LELETI, Manmohan, Reddy,MANDAL, Debashis,MILES, Dillon,POWERS, Jay,ROSEN, Brandon,THOMAS-TRAN, Rhiannon,SHARIF, Ehesan

申请号：

EP18741044

公开号：

EP3570844A4

申请日:

2018.01.19

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/